PDAC Prognosis Biomarkers in Genomic and Transcriptomic Molecular Data
Demographics (2)
- AGE_AT_INITIAL_PATHOLOGIC_DIAGNOSIS - Age of subject at initial pathologic diagnosis (phv00483085.v1.p1)
- SEX - Biological sex (phv00483073.v1.p1)
Race and Ethnicity (1)
- RACE - Human race (phv00483080.v1.p1)
Other (21)
- ADJUVANT_THERAPY - Adjuvante therapy status (phv00483094.v1.p1)
- ADJUVANT_TX. - Adjuvant Therapy status (phv00483083.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00483089.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00483088.v1.p1)
- CENSORED - Censoring occurrence (phv00483079.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00483072.v1.p1)
- FOLLOW_UP_DAYS - The days of care following a surgical procedure (phv00483078.v1.p1)
- FOLLOW_UP_VITAL_STATUS - Follow up vital status (phv00483077.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00483091.v1.p1)
- IS_TUMOR - Tumor status (phv00483090.v1.p1)
- PATHOLOGY_N_STAGE - AJCC 8th pathologic N stage (phv00483081.v1.p1)
- PATHOLOGY_T_STAGE - AJCC 8th pathologic T stage (phv00483082.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00483093.v1.p1)
- RESIDUAL_TUMOR - Residual tumor classification (phv00483084.v1.p1)
- SAMPLE_ID - Sample ID (phv00483087.v1.p1)
- SAMPLE_ID - Sample ID (phv00483075.v1.p1)
- SUBJECT_ID - Subject ID (phv00483076.v1.p1)
- SUBJECT_ID - Subject ID (phv00483071.v1.p1)
- SUBJECT_ID - Subject ID (phv00483074.v1.p1)
- TUMOR_STAGE_AJCC_8th - AJCC 8th Tumor stage (phv00483092.v1.p1)
- YEAR_OF_INITIAL_PATHOLOGIC_DIAGNOSIS - Year at initial pathologic diagnosis (phv00483086.v1.p1)